NL
IRMD icon

NKCFO LLC’s iRadimed IRMD Stock Holding History

NKCFO LLC’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76K Hold
790
– – 0.02% 99
2025
Q4 		$77K Sell
790
-560
-41% -$48K 0.02% 85
2025
Q3 		$96K Buy
+1,350
New +$90K 0.03% 92
2019
Q2 		– Sell
-3,550
Closed -$100K – 114
2019
Q1 		$100K Hold
3,550
– – 0.07% 76
2018
Q4 		$87K Buy
+3,550
New +$95.4K 0.07% 65

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NKCFO LLC's IRMD Position: Q1 2026 in Review

NKCFO LLC held its iRadimed (IRMD) position steady in Q1 2026 at 790 shares worth $76K. The position accounts for 0.02% of the portfolio, ranked #99.

NKCFO LLC first reported a position in IRMD in Q4 2018 and has held it in 5 quarters since. The position peaked at $100K in Q1 2019. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • NKCFO LLC held 790 shares of iRadimed worth $76K as of Q1 2026.
  • NKCFO LLC left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up 0.02% of NKCFO LLC's portfolio in Q1 2026, its #99 holding.
  • NKCFO LLC first reported a position in iRadimed in Q4 2018 and has held it in 5 quarters since.
  • NKCFO LLC's iRadimed position peaked at $100K in Q1 2019.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on NKCFO LLC's 13F filing for Q1 2026, filed 11 May 2026.